Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $79.20 -0.44 (-0.55%) (As of 09/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateOct. 25EstimatedActual EPS (Jul. 27) $1.00 Missed By -$0.10 Consensus EPS (Jul. 27) $1.10 Get Dr. Reddy's Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for RDY and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.71$0.71$0.71Q2 20241$0.88$0.88$0.88Q3 20241$0.87$0.87$0.87Q4 20241$0.86$0.86$0.86FY 20244$3.32$3.32$3.32Q1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$1.00$1.00$1.00FY 20254$4.09$4.09$4.09Q1 20261$1.01$1.01$1.01Q2 20261$0.99$0.99$0.99Q3 20261$1.00$1.00$1.00Q4 20261$1.04$1.04$1.04FY 20264$4.04$4.04$4.04Q1 20271$0.95$0.95$0.95RDY Earnings Date and InformationDr. Reddy's Laboratories last issued its earnings results on July 27th, 2024. The reported $1.00 earnings per share for the quarter, missing analysts' consensus estimates of $1.10 by $0.10. The firm had revenue of $919.80 million for the quarter, compared to analyst estimates of $861.68 million. Dr. Reddy's Laboratories has generated $4.03 earnings per share over the last year ($4.03 diluted earnings per share) and currently has a price-to-earnings ratio of 19.7. Earnings for Dr. Reddy's Laboratories are expected to grow by 0.49% in the coming year, from $4.11 to $4.13 per share. Dr. Reddy's Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 25th, 2024 based off prior year's report dates.Read More Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 10/25/2024(Estimated)------- 7/27/2024Q1 2025$1.10$1.00($0.10)$1.00$861.68 million$919.80 million5/7/2024Q4 2024$0.86$0.94+$0.08$0.94$825.20 million$850.00 million1/31/2024Q4 2023$0.88$0.99+$0.11$0.99$827.81 million$867.00 million 10/27/2023Q2 2024$0.88$1.07+$0.19$1.07$825.94 million$832.16 million7/26/2023Q1 2024$0.71$1.03+$0.32$1.03$790.67 million$820.20 million5/10/2023Q4 2023$0.57$0.70+$0.13$0.70$763.37 million$766.00 million Get the Latest News and Ratings for RDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dr. Reddy's Laboratories and its competitors with MarketBeat's FREE daily newsletter. 1/25/2023Q3 2023$0.60$0.91+$0.31$0.91$769.25 million$818.00 million10/28/2022Q2 2023$0.59$0.82+$0.23$0.82$763.28 million$775.00 million7/28/2022Q1 2023$0.58$0.90+$0.32$0.90$767.00 million$660.00 million5/19/2022Q4 2022-$0.53+$0.53$0.99-$717.00 million1/28/2022Q3 2022-$0.57+$0.57$0.57-$715.00 million10/29/2021Q3 2021$0.56$0.80+$0.24$0.80-$777.00 million7/27/2021Q2 2021$0.55$0.46($0.09)$0.46$685.22 million$662.00 million5/13/2021Q1 2021$0.51$0.46($0.05)$0.46-$646.00 million 1/29/2021Q3 2021-$0.41+$0.41$0.80-$675.00 million10/28/2020Q3 2020$0.50$0.62+$0.12$0.62-$666.00 million 7/29/2020Q2 2020$0.42$0.46+$0.04$0.46-$585.00 million 5/20/2020Q1 2020$0.49$0.61+$0.12$0.61$552.28 million$588.00 million 1/27/2020Q3 2020-$0.40+$0.40$1.28-$614.00 million11/1/2019Q2 2020-$0.93+$0.93$0.93-$680.00 million Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When is Dr. Reddy's Laboratories's earnings date? Dr. Reddy's Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 25th, 2024 based off last year's report dates. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) missed the analysts' consensus estimate of $1.10 by $0.10 with a reported earnings per share (EPS) of $1.00. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $288.51 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $668 million. RDY has generated $4.03 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories's price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 19.65 and a forward price-to-earnings ratio of 19.27. The price/earnings-to-growth ratio is 1.84. What is Dr. Reddy's Laboratories's EPS forecast for next year? Dr. Reddy's Laboratories's earnings are expected to grow from $4.11 per share to $4.13 per share in the next year, which is a 0.49% increase. More Earnings Resources from MarketBeat Related Companies: Takeda Pharmaceutical Earnings Date Moderna Earnings Date Teva Pharmaceutical Industries Earnings Date BioNTech Earnings Date BeiGene Earnings Date Genmab A/S Earnings Date Ginkgo Bioworks Earnings Date Viatris Earnings Date Sarepta Therapeutics Earnings Date Catalent Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NYSE:RDY) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredHere’s A Painful Truth and 100% Fact About The Stocks You’re HoldingCharles Payne here, and I want to let you in on an uncomfortable truth that long term investors and retirees n...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDY Stock Alerts